Celldex Therapeutics, Inc. Forecast and Target Price
$24.49
Celldex Therapeutics, Inc. (CLDX) Share Price Forecast
Currently 14 wall-street analysts regularly analyze the financials of Celldex Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 14 analysts offering 12-month price forecasts for Celldex Therapeutics, Inc. (CLDX) have a share price target of $67.1. This median of share price forecast represents a 173.99% upside from the latest price of $24.49 as on 01.02.25.
Celldex Therapeutics, Inc. (CLDX) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Celldex Therapeutics, Inc. (CLDX) share price will touch around $67.1 in next 12-months.
Celldex Therapeutics, Inc. (CLDX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Celldex Therapeutics, Inc.'s share price and its median forecast price. As on 01.02.25, the difference is -61.73%
Celldex Therapeutics, Inc. (CLDX): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Celldex Therapeutics, Inc. (CLDX) Share Price : Analyst Recommendation
Based on 14 analysts tracking and researching Celldex Therapeutics, Inc. (CLDX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 7 | 7 | 7 |
| Outperform | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Celldex Therapeutics, Inc. (CLDX) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
₹0 US Stocks a/c Opening Fee